MARKET

SRDX

SRDX

Surmodics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

48.03
+0.78
+1.65%
Opening 15:17 08/11 EDT
OPEN
47.92
PREV CLOSE
47.25
HIGH
48.05
LOW
46.81
VOLUME
37.60K
TURNOVER
--
52 WEEK HIGH
49.00
52 WEEK LOW
22.06
MARKET CAP
655.62M
P/E (TTM)
86.82
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SRDX stock price target is 64.25 with a high estimate of 76.00 and a low estimate of 57.00.

EPS

SRDX News

More
Surmodics (SRDX) Q3 Earnings and Revenues Beat Estimates
Zacks · 1d ago
SurModics (SRDX) Q3 Earnings and Revenues Top Estimates
SurModics (SRDX) delivered earnings and revenue surprises of 110.00% and 8.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 5d ago
Surmodics Reports Third Quarter Fiscal 2020 Results
Surmodics Reports Third Quarter Fiscal 2020 Results and will hold a webcast conference call at 4 pm CT.
Business Wire · 5d ago
Surmodics Receives FDA 510(k) Clearance for Sublime™ Radial Access 0.014 RX PTA Dilatation Catheter
Surmodics receives FDA 510(k) clearance for Sublime™ Radial Access 0.014 RX PTA Dilatation Catheter.
Business Wire · 5d ago
Analysts Estimate SurModics (SRDX) to Report a Decline in Earnings: What to Look Out for
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
Surmodics to Webcast Third Quarter Fiscal 2020 Earnings Conference Call on August 5
Surmodics issues an earnings release after market closes and will host a webcast of fiscal 2020 third-quarter conference call on August 5 at 4 pm CT.
Business Wire · 07/28 12:30
Earnings Preview: SurModics (SRDX) Q3 Earnings Expected to Decline
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/22 16:32
VREX vs. SRDX: Which Stock Is the Better Value Option?
VREX vs. SRDX: Which Stock Is the Better Value Option?
Zacks · 07/14 15:40

Industry

Medical Equipment, Supplies & Distribution
-0.33%
Healthcare Equipment & Supplies
-0.44%

Hot Stocks

Symbol
Price
%Change

About SRDX

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.
More

Webull offers kinds of SurModics, Inc. stock information, including NASDAQ:SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRDX stock methods without spending real money on the virtual paper trading platform.